02563 BIOSTAR PHARM-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 8.33X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | N/A |
| Total Debt/Equity | 0.1% | Return on Equity | N/A |
| Price/Book | 1.89X | Return on Assets | N/A |
| (HKD 3.840) | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | -146.30 | -152.91 | -209.03 | -179.96 |
|---|---|---|---|---|
| Net Profit Growth (%) | +4.3 | +26.9 | -16.2 | N/A |
| Earnings Per Share (HKD) | -0.401 | -0.434 | -0.597 | -0.514 |
| Earnings Per Share Growth (%) | +7.6 | +27.4 | -16.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 2.034 | 2.307 | N/A | N/A |
| Auditors' Opinion | N/A | Qualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 33.364 | 71.866 | -53.6 | 66.635 |
| Operating Result | -134.347 | -143.776 | -6.6 | -189.644 |
| Profit Before Taxation | -131.435 | -143.776 | -8.6 | -189.644 |
| Profit /( Loss) After Taxation | -131.435 | -143.776 | -8.6 | -189.644 |
| Net Profit | -131.435 | -143.776 | -8.6 | -189.644 |
| Earnings Per Share () | -0.4007 | -0.4338 | -7.6 | -0.5972 |
| Announcement Date | 2026-03-30 | 2025-06-30 | NA | 2024-10-23 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
